Skip to main content

ACR Convergence 2022 Main banner

Schedule at a Glance

Community Hub

Infection-related rheumatic syndromes

Format: Virtual Only

519: CH COVID-19: Long COVID in Rheumatology

Saturday, November 12, 2022

1:00 PM – 1:15 PM Eastern Time

All of the relevant financial relationships listed for faculty have been mitigated.

Community Speaker(s)

Leonard Calabrese, DO

Board Certified Rheumatologist and the Head, Section of Clinical Immunology Department of Rheumatic & Immunologic Disease
Cleveland Clinic
Cleveland, OH, United States

Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Chemocentryx: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Jansen: Advisor or Review Panel Member (Ongoing); Novartis: Consultant (Ongoing); UCB: Consultant (Ongoing)

Hub Host(s)

Alfred Kim, MD, PhD

Washington University School of Medicine
St. Louis, MO, United States

Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia Pharmaceuticals: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Exagen Diagnostics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Foghorn Therapeutics: Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Kypha Inc.: Consultant (Ongoing), Intellectual Property/Patents (Ongoing); Pfizer: Consultant (Ongoing)